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Upon HIV transmission, some patients develop AIDS in only a few months, while others remain disease free for 20 or
more years. This variation in the rate of disease progression is poorly understood and has been attributed to host
genetics, host immune responses, co-infection, viral genetics, and adaptation. Here, we develop a new ‘‘relaxed-clock’’
phylogenetic method to estimate absolute rates of synonymous and nonsynonymous substitution through time. We
identify an unexpected association between the synonymous substitution rate of HIV and disease progression
parameters. Since immune activation is the major determinant of HIV disease progression, we propose that this
process can also determine viral generation times, by creating favourable conditions for HIV replication. These
conclusions may apply more generally to HIV evolution, since we also observed an overall low synonymous
substitution rate for HIV-2, which is known to be less pathogenic than HIV-1 and capable of tempering the detrimental
effects of immune activation. Humoral immune responses, on the other hand, are the major determinant of
nonsynonymous rate changes through time in the envelope gene, and our relaxed-clock estimates support a decrease
in selective pressure as a consequence of immune system collapse.
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Introduction
Although the clinical course of HIV infection is generally
well-deﬁned, there is considerable variability among patients
in rates of disease progression. The highly variable asympto-
matic phase, ranging from several months to more than 20
years, most likely reﬂects differences in the nature of the
evolutionary arms race between the virus population and the
host immune system. Both humoral and cell-mediated
immune responses are mounted against the virus but are
eventually defeated by HIV replication and adaptation. As
part of this process, neutralizing antibodies (nAbs) exert a
strong selective pressure on the HIV envelope gene (env) [1,2]
but do not control viral replication, and nAb levels are not
predictive of disease progression [3]. Cytotoxic T cell (CTL)
responses play a more important protective role in HIV
infection, and evidence has shown that partial control of HIV
replication in vivo is temporally associated with the appear-
ance of CTL responses [4] and that the rate of disease
progression is strongly dependent on human leukocyte
antigen (HLA) class I alleles [5,6]. Although CTLs may not
be responsible for the majority of infected cell deaths, small
differences in CTL killing rates could still be clinically
relevant and alter the time of disease onset [7].
Unfortunately, the enormous potential for evolutionary
change in HIV can counteract these host defense responses.
High mutation and recombination rates coupled with rapid
replication dynamics generate a genetically diverse viral
population, enabling the infection of a large number of
susceptible cells. Consequently, HIV is able to adapt readily to
changing environmental conditions within each host. The
envelope protein is able to evade nAb responses by
accumulating multiple amino acid changes, especially in the
hypervariable regions, while maintaining full functionality
for viral cell entry. CTL responses, however, target epitopes
in other viral genes (such as gag and nef) more strongly and/or
more frequently, particularly during the initial stages of HIV
infection [8–10]. Although HIV infection often results in the
evolution of viral variants that escape CTL responses [11],
recent evidence from transmission pair studies and in vitro
growth rate studies suggests that some escape mutations
might occur at the expense of viral ﬁtness [12,13].
Although the immune response against HIV has become
increasingly well-characterized, less is known about the role
of viral evolution in disease progression, despite its impor-
Editor: Allen Rodrigo, University of Auckland, Australia
Received September 5, 2006; Accepted December 29, 2006; Published February
16, 2007
A previous version of this article appeared as an Early Online Release on January 2,
2007 (doi:10.1371/journal.pcbi.0030029.eor).
Copyright:  2007 Lemey et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Abbreviations: CTL, cytotoxic T cell; dN, nonsynonymous; dS, synonymous; HKY85,
Hasegawa–Kishino–Yano model; HLA, human leukocyte antigen; log VL, log viral
load; MCMC, Markov chain Monte Carlo; nAb, neutralizing antibody; SIV, simian
immunodeficiency virus; TCR, T cell receptor
* To whom correspondence should be addressed. E-mail: philippe.lemey@zoo.ox.
ac.uk
PLoS Computational Biology | www.ploscompbiol.org February 2007 | Volume 3 | Issue 2 | e29 0282tance to our understanding of virus–host dynamics during
persistent infection. Comprehensive sampling of C2V3 env
sequences from nine HIV-1 infected patients throughout the
entire course of HIV-1 infection revealed consistent patterns
of viral evolution: both genetic diversity of the viral
population at a given time point and mean divergence from
the founder strain increased approximately linearly during
infection [14]. However, diversity peaked at roughly the same
time that viruses using the CXCR4 coreceptors emerged,
whilst divergence did not stabilize until close to the time of
disease onset. Studies of viral diversity and divergence in
HIV-1 patients with different disease progression rates often
have conﬂicting results (e.g., [15,16]). Attempts to distinguish
between adaptive and selectively neutral mutations have
suggested that slower disease progression is associated with
more positively selected sites and higher adaptation rates in
env [17,18]. From an immunological perspective, however, it
remains unclear whether such viral adaptation is the cause or
consequence of variability in disease progression rates.
Although the physiological processes leading to CD4þT cell
depletion and AIDS are not clearly deﬁned, it is widely
accepted that persistent immune activation has a pivotal role
in driving disease progression [reviewed in 19]. T cell
activation is the strongest predictor of progression to AIDS
in HIV-1 infected patients [20,21] and can determine the rate
andcontinuityofviralreplication[19].Consequently,immune
activation could also impose important constraints on viral
generation times and HIV evolution. However, such effects
have not been established through evolutionary analyses.
The ratio of nonsynonymous/synonymous substitution
rates has proved useful in investigating molecular adaptation;
however, changes in the absolute rates of nonsynonymous and
synonymous substitution should provide greater insight [22].
Changes in synonymous substitution rates can reﬂect changes
in generation time or mutation rate, while nonsynonymous
rates can also be affected by changes in selective pressure and
effective population size. Previous studies of HIV evolution
have typically assumed that the rate of neutral or synonymous
change (per month or year) is approximately constant among
patients (e.g., [15,16]). This assumption may be inappropriate,
as the rate depends on the average number of viral
generations per unit time, which may vary. For example,
viral replication rates can depend on the state of immune
activation [23], viral strains may differ in their replicative
ability in different environments [12], and average virus
generation times can be affected by the dynamics of latently
infected cells [24,25].
To investigate these issues in HIV infection, we developed a
new statistical approach to estimate absolute rates of
synonymous and nonsynonymous substitutions and to deter-
mine how those rates change through time. Our method
extends previous relaxed-clock methods with codon model
analysis and allows evolutionary rates to change in an
uncorrelated fashion along branches in a genealogy [26]. By
comparing evolutionary rates for speciﬁc branches in within-
host HIV phylogenies, we correct for the potentially biasing
effects of transient deleterious polymorphism. Using this
approach, we investigate the relationships among viral
substitution rates, disease progression, and host immune
responses. Our results show that disease progression among
patients is predicted by synonymous substitution rates, most
likely reﬂecting different levels of persistent immune
activation, while nonsynonymous rates evolve within patients
as a consequence of changing antibody selective pressure.
Results
We estimated rates of nonsynonymous (dN) and synon-
ymous (dS) divergence using longitudinal env sequence data
from nine HIV-1 infected individuals [14,27]. The high
mutation rate of HIV is expected to lead to a considerable
deleterious mutation load in the viral population, such that
the most recent mutations, segregating on external branches
of HIV phylogenies, are likely to be deleterious [28,29]. This
effect is present in each of the nine patients analyzed; mean
substitution rates were consistently higher for external
branches than for internal branches (Figure 1). Simulations
indicated that such differences were not expected under a
neutral model (Table S1). We also found no evidence
supporting a link between high external rates and recombi-
nation rates for each time point (Table S2).
Transient deleterious mutations do contribute to HIV
evolution but not to the process of nucleotide substitution,
since they are, most probably, rapidly puriﬁed [29]. Because
inclusion of deleterious mutations could bias our estimates of
divergence and absolute evolutionary rate, we estimated
mean rates of divergence for two sets of branches: internal
branches, and ‘‘backbone’’ branches representing the central
lineage of the phylogeny that persists through time (Figure 1;
see Methods for a phylogenetic deﬁnition of the backbone;
speciﬁc details of the backbone, internal, and external
branches for the other patients can be found in Figure S1).
Estimates of synonymous and nonsynonymous divergence for
internal and backbone branches are shown in Figure 2. When
patients are classiﬁed as moderate or slow progressors (based
on progression time, or the time it takes for the CD4þ T cell
count to drop below 200 cells/ll; [17]), virus populations in
slow progressors appear to accumulate synonymous substi-
tutions more slowly than those in moderate progressors
(Figure 2). This relationship is not apparent for nonsynon-
ymous divergence.
We investigated correlations between HIV divergence
rates, estimated from the root of the within-host genealogies
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Author Summary
During the clinical course of HIV infection, an asymptomatic phase
always precedes the acquired immunodeficiency syndrome (AIDS).
The duration of this asymptomatic phase is highly variable among
patients and reflects the rate at which the immune system gradually
deteriorates. Although humoral and cell-mediated immune re-
sponses are mounted against HIV, continuous replication and
adaptation allows the virus to escape host immune responses. To
gain a better understanding of the role of viral evolution in disease
progression, we developed a new computational technique that can
estimate changes in the absolute rates of synonymous and
nonsynonymous divergence through time from molecular sequen-
ces. Using this type of evolutionary inference, we have identified a
previously unknown association between the ‘‘silent’’ evolutionary
rate of HIV and the rate of disease progression in infected
individuals. This finding demonstrates that cellular immune pro-
cesses, which are already known to determine HIV pathogenesis,
also determine viral replication rates and therefore impose
important constraints on HIV evolution.
Rates of HIV Evolution and AIDS Progressionto progression time, and three continuous parameters that
relate to disease progression: progression time, the rate of
CD4þT cell count change over time, and the rate of log viral
load (log VL) change over time (Figure 3). The log of the
backbone rate of synonymous divergence shows a strong
negative correlation with both progression time (Pearson
correlation coefﬁcient r¼ 0.79, p¼0.011) and the change in
CD4þ T cell count (r ¼  0.72, p ¼ 0.028), and a moderate
positive correlation with the change in log VL (r ¼ 0.65, p ¼
0.059). No signiﬁcant correlations were observed for non-
synonymous divergence rates (r ¼  0.32, p ¼ 0.40 for
progression time; r ¼  0.54, p ¼ 0.135 for CD4þ T cell count
change; r ¼  0.14, p ¼ 0.58 for log VL change). Similar results
were obtained when divergence rates were estimated from
internal branches (Figure S2). In contrast to backbone and
internal rates, no signiﬁcant correlations were observed for
both dS and dN rates on external branches. Similar results
were also obtained when datasets were restricted to samples
up to about 70 months after seroconversion (Figure S3),
indicating that the differences in dS rate estimates could not
be attributed to differences in time length of sampling. In
general, backbone dS rates before progression time seem to
show little temporal ﬂuctuation in the trees since dS
divergence accumulated in a linear fashion, with R
2 values
close to 0.96, except for patient 9 (R
2 ¼ 0.83). We also
investigated the heterogeneity of synonymous and non-
synonymous substitution rates within the env C2V3 gene,
because strong site-to-site variation in synonymous rates has
the potential to bias dS estimates [30]. Although this analysis
revealed very strong site-to-site variation in dS rates, the
inferred rate distributions were nearly identical among all
patients (Table S3). Finally, recombination rate estimates
(Table S2) did not provide any evidence that recombination
could be the cause of the differences between dS estimates.
The variability in dS rates could reﬂect differences in either
viral mutation rate or viral generation time, but only the
latter provides a likely explanation for the correlation
between dS rates and disease progression. However, viral
generation time is also expected to affect dN rates to some
extent. While we did not observe a signiﬁcant correlation, this
Figure 1. Internal, Backbone, and External Branches in a Within-Host HIV Genealogy, and Mean Nucleotide Substitution Rates for These Branches in
Nine Longitudinally Sampled HIV-1 Patients
To avoid the influence of deleterious mutations segregating to external branches in intrapatient HIV genealogies, we estimate mean substitution rates
for the set of internal and backbone branches. These branch sets are depicted in color in the maximum a posteriori tree for ‘‘patient 1’’ obtained by
Bayesian relaxed-clock inference [26] (backbone, red; internal, blue; external, black). The backbone represents the central trunk of trees shaped by rapid
lineage turnover and can be defined phylogenetically (see Methods). Note that the set of internal branches also includes the backbone branches.
Samples for each time point are indicated by the dotted line. Mean nucleotide substitution rates and their standard deviations on internal, external, and
backbone branches are shown for all longitudinally sampled HIV-1 patients. The consistently higher substitution rate on external branches might be
indicative of higher mutation load on these branches.
doi:10.1371/journal.pcbi.0030029.g001
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Rates of HIV Evolution and AIDS Progressionmay be because dN rates are determined primarily by the
strength of selection on viral mutations, rather than by the
absolute rate at which those mutations are generated.
Furthermore, most diversifying selection in env results from
nAb responses [31], which are not expected to moderate
replication rates and disease progression. To demonstrate
this, we further analyzed env sequences sampled through time
from two patients with markedly distinct rates of phenotypic
escape from nAb responses [31] (patient 01–0083 and patient
01–0127; Figure 4). As in Frost et al. [2], we show that the virus
that rapidly escaped nAb responses in patient 01–0127
accumulated nonsynonymous substitutions at a considerably
higher rate on backbone branches, while synonymous
divergence rates appear to be unaffected (similar plots were
obtained for internal branches, unpublished data).
Because it has been shown that viral divergence stabilizes
close to disease onset [14], we estimated mean divergence
rates prior to the progression time in the analyses above. Two
hypotheses have been proposed to explain this stabilization:
reduced availability of target cells late in infection (the
‘‘cellular exhaustion’’ hypothesis), or reduced selective
pressure because of deteriorating immune responses (the
‘‘immune relaxation’’ hypothesis) [32]. A recent statistical
analysis provided support for the immune relaxation hy-
pothesis by showing that nonsynonymous divergence stabil-
izes at about the same time as progression time, while
synonymous divergence does not [32]. Our analysis provides
further evidence that nonsynonymous divergence stabilizes in
some patients and that this is less pronounced for synon-
ymous divergence (Figure 2). Using the empirical relaxed-
clock approach, we directly estimated dN and dS substitution
rates before and after progression time (Table 1). These
estimates indicate that dN is signiﬁcantly lower after
progression time both for internal and backbone branches
(paired t test: p ¼ 0.012 and p ¼ 0.001, respectively; Wilcoxon
signed rank test: p ¼ 0.016 and p ¼ 0.008, respectively), while
there is no signiﬁcant difference in dS before and after
progression time (paired t test: p ¼ 0.424 and p ¼ 0.333,
respectively; Wilcoxon signed rank test: p¼0.461 for internal
and backbone branches).
As an extension to the analysis of closely related HIV-1
strains, we further explored differences among within-patient
substitution rates for more divergent HIV lineages. Table 2
lists average dS and dN rates for HIV-1 subtype B infected
patients, HIV-1 group O infections, and HIV-2 datasets.
Although studies of HIV-1 group O infection are limited, no
differences in disease progression between group O and
group M infections have been observed [33]. HIV-2, on the
Figure 2. Mean Synonymous and Nonsynonymous Divergence for Internal and Backbone Branches over the Course of HIV Infection in Nine Individuals
Patients with moderate and slow disease progression, categorized by progression time less than or greater than seven years [17], are shown in pink and
blue, respectively. Individual patient numbers from Shankarappa et al. [14] are shown in circles, and progression times for each patient are indicated in
italics.
doi:10.1371/journal.pcbi.0030029.g002
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Rates of HIV Evolution and AIDS Progressionother hand, is known to be less transmissible and less
pathogenic than HIV-1 group M [34,35]. The two HIV-1
group O datasets had dS rates that were similar to the rates
estimated for HIV-1 subtype B moderate progressors (Table
2). Clinical data for these HIV-1 group O patients indeed
indicate progression times in the range of moderate
progressors (60 and 70 months; [33,36]). In contrast, HIV-2
patients had dS rates that were more comparable with HIV-1
group M slow progressors (Table 2). The two published HIV-2
datasets (P7P8 and P9P10) represent cases of perinatal
transmission only diagnosed in adulthood [37], as expected,
given the slow nature of HIV-2 disease progression. HIV-2 dN
rates are in the same range of HIV-1 dN rates in both
moderate and slow progressors. Interestingly, the observation
that group O viruses are characterized by a high dN is in
agreement with a population-level study that identiﬁed more
sites under positive selection in env for HIV-1 group O than
for HIV-1 group M or HIV-2 [38].
Discussion
The relationship between HIV evolution and disease
progression is central to our understanding of immune
control and to vaccine design. Although much research effort
has been focused on this issue, a clear and coherent picture of
HIV evolutionary dynamics has yet to be presented. Here, we
develop a novel computational approach to estimate the
absolute rates of synonymous and nonsynonymous substitu-
tion during the course of HIV infection.
Our analyses reveal that slower progression to AIDS is
strongly correlated with a slower rate of synonymous
substitution, indicative of a slower replication rate and
longer viral generation times. This reasoning assumes that
synonymous substitutions are selectively neutral. Although
synonymous mutations may inﬂuence ﬁtness in viral pop-
ulations, experimental exploration of ﬁtness effects caused by
single-nucleotide substitutions in vesicular stomatitis virus
clearly showed that synonymous changes were roughly
neutral [39]. The strong site-to-site variation in dS does
suggest that selection is acting on synonymous substitutions
in the HIV-1 env gene, but the highly similar distribution of
rate variation implies that possible biases, if any, will affect all
patients similarly. The similar site-to-site variation in dS for
all patients also suggests that slower disease progression is not
associated with stronger purifying selection, which could be a
less likely alternative to explain the lower dS rates.
Because persistent immune activation is an important
process underlying disease progression [19], it may provide a
Figure 3. Scatter Plots of Mean Synonymous (A) and Nonsynonymous (B) Substitution Rates on Backbone Branches as a Function of Progression Time,
CD4þ T Cell Count Slope, and Log Viral Load Slope
Rates as a function of progression time and the slope of the CD4þT cell count are shown in pink, while rates as a function of the log VL slope are shown
in cyan. The progression time for patient 11 was set at the last sampling time (144 months), although the CD4þcount had not dropped below 200 cells/
ll at that time [14,17]. The slope of the CD4þ T cell count and log VL were calculated based on linear regression of these parameters as a function of
time. The error bars represent the standard errors of the estimates.
doi:10.1371/journal.pcbi.0030029.g003
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Rates of HIV Evolution and AIDS Progressionplausible explanation for differences in replication rates. The
transcriptional machinery within the nucleus of the host cell
is responsible for viral gene expression, making the HIV life
cycle critically dependent on the activation state of the host
cell [40]. HIV can infect resting CD4þT cells, but after reverse
transcription the pre-integration complex is degraded unless
the cell is activated within a few days [41]. Immune activation,
which is a strong predictor of progression to AIDS [20], is
therefore a major stimulus for viral replication at the cellular
level [40]. In addition, it is believed that T cell activation
recruits large numbers of rapidly proliferating, short-lived,
activated target CD4þ T cells, thereby creating the ideal
condition for increased viral replication, while at the same
time causing premature aging and exhaustion of the naı ¨ve T
cell pool [23]. Experimental evidence indicates that this
process is characterized by repeated bursts of viral repli-
cation, which have been suggested as a critical driver for the
continuity of viral replication [19]. Transmission of free virus
will only be efﬁcient when target cells are in close proximity
[e.g., 42], and infection of new cells is largely restricted to
microscopic clusters of T cells in lymphoid tissue [e.g., 43],
emphasizing the need for recruitment of uninfected activated
CD4þ cells through immune activation. Because of both
proliferation and activation of target cells, it is not surprising
that the state of immune activation will affect HIV generation
times and impose important constraints on viral evolution.
The cause of immune activation is not clearly established, but
it has been suggested that defective virus, which is the
primary product of HIV replication, can drive immune
activation [44]. If HIV itself plays a central role in immune
activation, more replication will reinforce further the state of
immune activation.
Recent ﬁndings show that Nef-mediated T cell receptor
(TCR)–CD3 down-modulation is capable of protecting
against immune activation and activation-induced cell death
for most simian immunodeﬁciency viruses (SIV) [45]. This
function has been generally conserved in primate lentiviral
evolution but lost in the chimpanzee precursor of HIV-1,
SIVcpz [45]. Therefore, these ﬁndings seem to resolve the
longstanding issue of the nonpathogenic nature of SIV
infection. In addition, it provides an explanation for the
lower pathogenicity of HIV-2 infections [35] and the
generally low HIV-2 synonymous substitution rates observed
in this study. Nef-mediated TCR-CD3 down-modulation also
correlated with CD4þ T cell depletion in SIVsmm infected
sooty mangabeys [45]. A similar phenomenon might therefore
be important for differences in pathogenicity in HIV-1
moderate and slow progressing patients. In contrast to an
active suppression of immune activation in most SIV/HIV-2
infections, HIV-1 Nef can even increase immune activation
[45], and patients infected with nef-defective HIV-1 have been
reported to exhibit a slow progressing or even nonprogress-
ing phenotype [46,47]. No doubt other viral and host factors
will be important to explain differences between HIV/SIV
infections. For example, SIVsmm infections usually exhibit
high viral loads, while in asymptomatic HIV-2 infections viral
loads are often too low to be detected. Recently, a low
replicative capacity of HIV-2 compared with HIV-1 variants
has been demonstrated [48]. Producing fewer viral particles
per replication cycle will result in lower viral loads and may
also constitute a lower stimulus for immune activation.
While immune activation provides a likely cause for the
observed differences, there may be other explanations for a
generation time effect in patients with different disease
progression. For example, there may exist an evolutionary
tradeoff between immune escape and replication rate. In the
absence of immunological pressure, natural selection for fast
replication rates would dominate viral evolution [49]. In the
presence of an immune response, however, a tradeoff
between immune escape and replication rate might be
expected. There is evidence that the CTL escape response
can indeed reduce replicative ﬁtness by forcing the virus to
endure detrimental CTL escape mutations [12,13]. Therefore,
a vigorous CTL might be indirectly responsible for control of
viral replication, longer HIV generation times, and slower
disease progression. Differences in replication rate might also
reﬂect differences in the contribution of the latent HIV
reservoir to the circulating virus population. The pool of
Figure 4. Internal Synonymous and Nonsynonymous Divergence in Two Patients with Distinct Phenotypic Escape from Neutralizing Antibodies
Nonsynonymous and synonymous divergence is shown for complete env sequences serially sampled from patient 01–0083 (A), whose virus exhibited
slow escape from neutralizing antibodies, and from patient 01–0127 (B), whose virus exhibited rapid escape from neutralizing antibodies [2]. The thick
lines depict the mean divergence and the colored areas represent the 95% credibility intervals.
doi:10.1371/journal.pcbi.0030029.g004
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Rates of HIV Evolution and AIDS Progressionresting memory CD4þ T cells that carry integrated proviral
genomes represents a stable reservoir for latent HIV
infection. Although they may produce only a fraction of
circulating viruses, modelling studies predict that such
latently infected cells can still considerably impact mean
generation times and replication rates [24,25]. The contribu-
tion of this reservoir to the free-ﬂoating virus population will
become more important as CTL killing of infected activated
CD4þ T cells becomes more efﬁcient. Latently infected cells
are also presumed to play a central role in the continuity of
viral replication during chronic immune activation [19].
Between bursts of viral replication induced by immune
activation, shedding of the virus in memory CD4þ T cells
may be required [19]. Because it is hypothesized that
replicative bursts are dependent on initial activation of these
memory CD4þT cells, this might be an additional mechanism
by which viral generation times are affected by the state of
immune activation. Multiple, overlapping, and nonsynchron-
ized bursts will occur in spatially separated lymphoid tissue
[19], which explains why viral replication may still be
continuous and average genetic divergence can increase in
an approximately linear fashion. Although CTL escape/viral
attenuation and the dynamics of the latent reservoir can be
involved in HIV generation times, they represent somewhat
less direct explanations and require more experimental
validation.
Our results show that the nonsynonymous rates in the env
gene, most likely effecting phenotypic escape from nAbs
(Figure 4, [2]), do not correlate with disease progression in
patients harbouring HIV-1 group M viruses. While these
conclusions are based on serial sampled data for only two
patients, Frost et al. [2] have clearly demonstrated this effect
in multiple patients. Crucially, we show that the selection
pressure on env obscures the expected correlation between
overall nucleotide substitution rates and disease progression,
emphasizing the need to disentangle the contributions of
synonymous and nonsynonymous substitutions to HIV
evolution. Once these absolute rates are separated, we
observe a signiﬁcant decrease in dN rates after progression
time, conﬁrming the hypothesis of immune relaxation during
the AIDS stage [32]. We conclude that this immune relaxation
reﬂects attenuated humoral immunity, which is probably a
consequence, rather than a cause, of variation in disease
progression. This concept is supported by ﬁndings that AIDS
patients with deteriorated immune responses usually have
lower antibody titers than asymptomatic patients (e.g., [50]).
Because it has been suggested that CXCR4-using viruses are
subjected to stronger immune control in vivo [51], immune
Table 1. Mean Synonymous and Nonsynonymous Substitution Rates Before and After Disease Progression
Patient Internal Rate (Substitutions/Site/Month)
Synonymous Nonsynonymous
,s .s ,s .s
P1 3.45 3 10
 04 6 5.92 3 10
 05 5.81 3 10
 04 6 1.25 3 10
 04 5.41 3 10
 04 6 7.97 3 10
 05 4.51 3 10
 04 6 1.23 3 10
 04
P2 3.07 3 10
 04 6 3.51 3 10
 05 2.77 3 10
 04 6 4.84 3 10
 05 8.69 3 10
 04 6 8.44 3 10
 05 2.61 3 10
 04 6 4.79 3 10
 05
P3 3.73 3 10
 04 6 5.93 3 10
 05 5.42 3 10
 04 6 1.87 3 10
 04 1.41 3 10
 03 6 1.65 3 10
 04 1.31 3 10
 03 6 4.48 3 10
 04
P5 7.92 3 10
 04 6 1.00 3 10
 04 5.65 3 10
 04 6 3.16 3 10
 04 8.46 3 10
 04 6 1.13 3 10
 04 8.85 3 10
 04 6 4.28 3 10
 04
P6 4.46 3 10
 04 6 7.95 3 10
 05 4.59 3 10
 04 6 1.68 3 10
 04 5.18 3 10
 04 6 9.39 3 10
 05 8.28 3 10
 05 6 7.84 3 10
 05
P7 2.24 3 10
 04 6 3.62 3 10
 05 1.89 3 10
 04 6 5.06 3 10
 05 9.48 3 10
 04 6 1.00 3 10
 04 7.37 3 10
 04 6 1.13 3 10
 04
P8 3.71 3 10
 04 6 5.23 3 10
 05 5.54 3 10
 04 6 8.71 3 10
 05 9.24 3 10
 04 6 9.72 3 10
 05 6.81 3 10
 04 6 1.02 3 10
 04
P9 1.57 3 10
 04 6 2.66 3 10
 05 2.09 3 10
 04 6 7.55 3 10
 05 5.26 3 10
 04 6 7.46 3 10
 05 2.11 3 10
 04 6 2.66 3 10
 05
Substitution rates and standard deviations are listed in synonymous or nonsynonymous substitutions per site per month. s represents the progression time in months for the different
patients (s ¼78, 96, 84, 72, 60, 78, 72, 132, respectively). The highest values for the comparison of rates before and after progression time are shown in bold. Nonsynonymous rates are
significantly different before and after s across patients. Patient 11 was not included since no samples were available after progression time [14,17].
doi:10.1371/journal.pcbi.0030029.t001
Table 1. Extended.
Patient Backbone Rate (Substitutions/Site/Month)
Synonymous Nonsynonymous
,s .s ,s .s
P1 5.64 3 10
 04 6 1.79 3 10
 04 5.81 3 10
 04 6 1.25 3 10
 04 7.59 3 10
 04 6 1.61 3 10
 04 3.34 3 10
 04 6 1.44 3 10
 04
P2 2.95 3 10
 04 6 7.39 3 10
 05 2.42 3 10
 04 6 6.76 3 10
 05 1.01 3 10
 03 6 1.71 3 10
 04 1.94 3 10
 04 6 6.21 3 10
 05
P3 2.16 3 10
 04 6 6.97 3 10
 05 3.04 3 10
 04 6 6.90 3 10
 04 2.21 3 10
 03 6 2.75 3 10
 04 1.16 3 10
 03 6 3.25 3 10
 03
P5 4.87 3 10
 04 6 1.21 3 10
 04 4.75 3 10
 04 6 3.55 3 10
 04 1.52 3 10
 03 6 2.95 3 10
 04 1.34 3 10
 03 6 6.23 3 10
 04
P6 3.93 3 10
 04 6 1.04 3 10
 04 1.96 3 10
 04 6 1.64 3 10
 04 4.61 3 10
 04 6 1.23 3 10
 04 1.60 3 10
 05 6 5.29 3 10
 05
P7 2.79 3 10
 04 6 8.05 3 10
 05 1.93 3 10
 04 6 3.32 3 10
 04 1.10 3 10
 03 6 2.02 3 10
 04 6.88 3 10
 04 6 1.55 3 10
 04
P8 2.82 3 10
 04 6 9.67 3 10
 05 3.16 3 10
 04 6 8.54 3 10
 05 9.60 3 10
 04 6 1.70 3 10
 04 6.82 3 10
 04 6 1.30 3 10
 04
P9 1.56 3 10
 04 6 4.17 3 10
 05 1.11 3 10
 04 6 2.38 3 10
 04 7.01 3 10
 04 6 1.18 3 10
 04 1.07 3 10
 04 6 7.43 3 10
 05
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with a high in vitro replication capacity and increased target
cell range generally do not appear until relatively late in HIV
infection.
Our results suggest that nAbs are not an important factor
in HIV disease progression. In this context, it is interesting to
note that autologous nAb response is poor or nonexistent
both in HIV-1 elite controllers [52] and HIV-2 infected
patients (N. Taveira, unpublished data). However, previous
studies have reported higher adaptation rates and more
persistently positively selected sites in slow-progressing
patients [17,18]. On the one hand, this discrepancy may
suggest that nAbs, in particular broadly neutralizing anti-
bodies, are able to moderate disease progression to some
degree. On the other hand, we cannot exclude the possibility
that adaptation rates and positive selected sites in env may
reﬂect CTL selective pressure to some extent. Finally,
phylodynamic processes, which explain the net viral adapta-
tion rate as the interaction between viral abundance and
selective pressure [53], must also be considered in HIV
evolution. More research is needed to establish the relation-
ship among immune responses, viral adaptation rates, and
disease progression in HIV infection.
Although a procedure for estimating rates of synonymous
and nonsynonymous substitution through time has been
developed previously [22], there are some advantages to this
approach. While Seo et al. [22] assume that the tree topology
is known without error, we allow for uncertainty in the
reconstructed genealogy. Our deﬁnition of internal and
backbone branches is a phylogenetic one, but we average
over a set of plausible trees in an empirical fashion and we
also incorporate sampling time information. Seo et al. [22]
were able to test whether changes in synonymous and
nonsynonymous rates are correlated, whereas we model
changes in the overall substitution rate (in an uncorrelated
fashion [26]), after which the synonymous and nonsynon-
ymous component for each branch is decoded using
maximum likelihood methods. It is possible that a full
probabilistic treatment of genealogical uncertainty and
independent changes in synonymous and nonsynonymous
rate could be developed. However, overcoming the technical
hurdles required to achieve this objective is beyond the scope
of this study. In this genealogical framework, we do not
account for the process of within-host recombination, which
can considerably shape HIV diversity [54]. Although recom-
bination could lead to inﬂated dN/dS estimates [55], there is
no reason to expect that recombination would affect
synonymous rates in a way that correlates with disease
progression. This was supported by the lack of clear
correlations between dS and recombination rate estimates.
In conclusion, our evolutionary analysis revealed a strong
correlation between synonymous substitution rates and HIV
disease progression. Further work will be necessary, however,
to clearly establish the mechanisms that determine HIV
generation times. A combined approach incorporating both
experimental and computational techniques should provide
important insights into the patterns of HIV evolution and
disease progression.
Materials and Methods
Estimating absolute rates of synonymous and nonsynonymous
substitution. Our approach to infer synonymous and nonsynonymous
substitution rates, and to explore how these rates change through
time, is an empirical extension of recently developed Bayesian
relaxed-clock models [26]. Given a ﬁxed tree topology, branch lengths
measured in units of expected synonymous and nonsynonymous
substitutions can be estimated using codon substitution models. We
applied a codon-based extension of the Hasegawa–Kishino–Yano
model (HKY85) (MG94xHKY85 with codon equilibrium frequencies
estimated from position-speciﬁc nucleotide frequencies, [56]), for
which the rate matrix for substituting codon x with codon y in
inﬁnitesimal time, Qx,y (a,b,j), is given by:
apny x ! y, 1-step synonymous transition,
ajpny x ! y, 1-step synonymous transversion,
bpny x ! y, 1-step nonsynonymous transition,
bjpny x ! y, 1-step nonsynonymous transversion, and
0 otherwise. (1)
In this parameterization, a denotes the synonymous substitution
rate, while b denotes the nonsynonymous substitution rate, and their
ratio (x ¼ b/a) reﬂects the strength of selective pressure along a
speciﬁc branch. j is the transversion/transition ratio, and pny
represents the frequency of the target nucleotide at the appropriate
codon position. The parameters a and b can be shared among
branches (equivalent to the ‘‘one-ratio’’ model; [57]) or allowed to
take up branch-speciﬁc values (equivalent to the ‘‘free-ratio’’ model;
[57]). We applied the latter, dubbed the ‘‘local’’ codon model, which
has the following form for the expected number of substitutions per
site on branch bi:
EsubðbiÞ¼tai½f1ðpÞþjf2ðpÞ  þ tbi½ g1ðpÞþjg2ðpÞ ; ð2Þ
where f1, f2, g1, and g2 are functions determined by the nucleotide
composition of the sequence alignment and shared among branches
[58]. The ﬁrst term in the sum corresponds to the contribution of
synonymous substitutions (a product of the branch-speciﬁc a) and the
second to the contribution of nonsynonymous substitutions (a
product of the branch-speciﬁc b). The time parameter t is not
estimable alone but products tai and tbi are.
In this codon model, the time parameter t could be estimated
assuming a dated tip molecular clock model, thereby providing
absolute rates of synonymous and nonsynonymous substitution [59].
Table 2. Mean Synonymous and Nonsynonymous Substitution Rates for Different HIV Variants
Dataset
Internal Rate (Substitutions/Site/Month) Backbone Rate (Substitutions/Site/Month)
Synonymous Nonsynonymous Synonymous Nonsynonymous
HIV-1 M moderate 5.63 3 10
 04 6 3.10 3 10
 04 8.68 3 10
 04 6 2.13 3 10
 04 5.06 3 10
 04 6 2.35 3 10
 04 1.15 3 10
 03 6 4.12 3 10
 04
HIV-1 M slow 3.59 3 10
 04 6 1.71 3 10
 04 7.07 3 10
 04 6 4.68 3 10
 04 3.01 3 10
 04 6 1.10 3 10
 04 1.12 3 10
 03 6 5.48 3 10
 04
HIV-1 O 6.46 3 10
 04 6 1.82 3 10
 04 3.19 3 10
 03 6 1.20 3 10
 03 5.28 3 10
 04 6 6.79 3 10
 05 3.13 3 10
 03 6 5.23 3 10
 04
HIV-2 2.41 3 10
 04 6 1.05 3 10
 04 7.19 3 10
 04 6 6.32 3 10
 04 2.60 3 10
 04 6 1.44 3 10
 04 5.38 3 10
 04 6 4.55 3 10
 04
Substitution rates and standard deviations are listed in substitutions per site per month for HIV-1 group M [subtype B, 14], HIV-1 group O [33,36], and HIV-2 [37,66,68] datasets. The HIV-1
group M infected patients are ordered according to increasing progression time. A detailed table of synonymous and nonsynonymous substitution rates for each dataset separately is
provided in Table S4.
doi:10.1371/journal.pcbi.0030029.t002
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however, the assumption of a strict molecular clock needs to be
relaxed (e.g., [22]). Recently, a relaxed-clock approach has been
developed that is applicable to measurably evolving populations and
takes into account genealogical uncertainty by averaging over a set of
plausible trees [26]. Since the sampling of genealogies using codon
models is too computationally expensive at present, we applied an
empirical extension of the relaxed phylogenetic model and sample
trees under the equivalent nucleotide substitution model.
We used Markov chain Monte Carlo (MCMC) methods as
implemented in BEAST 1.3 to obtain a posterior distribution of
trees under an uncorrelated relaxed clock [60,61]. In this approach,
the nucleotide substitution rate on each branch of the tree is drawn
independently and identically from an underlying rate distribution
[26], in this case an exponential prior distribution among branches.
Our full Bayesian probabilistic treatment is characterized by the
following posterior distribution:
fðg;H;k;XjDÞ¼
1
Z
PrfDjg;k;Xgf GðgjHÞf HXkðH;X;kÞð 3Þ
where g represents the tree topology and H contains the hyper-
parameters of the tree prior. We used a piecewise-constant model of
population size, the Bayesian skyline plot model, that provides
population size estimates for each coalescent interval of the
genealogy g [62]. H contains both the parameters for the group sizes,
which deﬁne the number of coalescent events in each grouped
interval, and the population size for each group. The relaxed-clock
parameter k represents the exponential distribution of rates across
lineages (with mean and standard deviation k
 1) [26]. Because we used
the HKY85 of nucleotide substitution with gamma-distributed rate
variation among sites, the vector X contains the transition/trans-
version ratio (j) and the shape of the gamma distribution (a). The
posterior density was investigated using MCMC with the length of the
chains, sampling frequency, and burn-in dependent on the dataset
analyzed. The MCMC samples were inspected for convergence to
stationarity, and effective sampling sizes were calculated using Tracer
1.2 [63].
Using the relaxed-clock approach, a posterior distribution of tree
topologies can be obtained with branch lengths in units of time and
in units of the expected number of nucleotide substitution per site,
both related by the vector of rates for the branches [26]. To infer
branch lengths in the expected number of synonymous and non-
synonymous substitutions separately, we applied the local codon
model to a set of trees sampled from the posterior distribution. To
achieve computational tractability and convergence under this
parameter-rich scheme (for reasonably large datasets, both in terms
of the number of taxa and the number of posterior trees), we inferred
the maximum likelihood estimates of the parameters while con-
straining the branch lengths (Esub) to the codon-rescaled estimates
obtained by the Bayesian relaxed-clock analysis. This allowed us to
determine the nonsynonymous and synonymous component of the
branch lengths, and using the Bayesian estimate for branches in time
units for each tree, absolute rates of nonsynonymous and synon-
ymous substitutions could be inferred and empirically averaged over
a set of genealogies. It has been shown that ﬁxing branch lengths has a
negligible effect on secondary nonsynonymous and synonymous rate
inference [64]. For each dataset, maximum likelihood estimation was
performed using HYPHY version 0.99 based on 200 trees sampled
from the posterior distribution [65]. Scripts to perform local codon
analysis on a set of trees in HYPHY are available at http://evolve.zoo.
ox.ac.uk and http://www.hyphy.org. Within-gene variation of synon-
ymous and nonsynonymous substitution rates was analyzed using
codon models that incorporate site-to-site heterogeneity of both dS
and dN [30].
Under the uncorrelated relaxed clock, it is possible to infer
individual rates for all branches in a genealogy and, thus, also a mean
rate for each subset of branches. Our analysis focuses on within-host
HIV genealogies, for which terminal branches may have an excess of
short-lived deleterious mutations that have not reached ﬁxation.
Therefore, we estimated mean substitution rates for internal
branches and for the central trunk of the ladder-like genealogies,
referred to as the ‘‘backbone’’ (Figure 1). We deﬁne the backbone as
the set of branches connecting the root of the tree to the sequences
sampled at the last time point, excluding both terminal branches and
internal branches from a common ancestor of sequences sampled at
the last time point only. Weighted averages were used to report mean
substitution rates for a set of branches, as deﬁned by Drummond et
al. [26]. Mean substitution rates before or after progression time were
calculated as weighted averages for the set of branches (or partial
branches) before or after that time point in the tree. Nonsynonymous
and synonymous divergence over time was estimated by calculating
the mean accumulation of substitutions along the lineages in a
particular time interval and averaging them over the set of
genealogies. Software to plot divergence over time and to obtain
substitution rates for a subset of branches is available from the
authors on request.
Datasets. Substitution rates in relationship to disease progression
were investigated in nine patients extensively sampled over a 6–13.7
year period starting close to the time of seroconversion [14,27]. Both
the Shankarappa et al. [14] C2V3 env sequence data and the Shriner et
al. (2004) [27] follow-up sequences were analyzed. Complete env gene
sequences longitudinally sampled from two patients with distinct
phenotypic escape form nAbs were obtained from Frost et al. [2].
Heterochronous HIV-1 group O env data were obtained from the two
available intrapatient evolution studies [33,36]. For HIV-2, we
analyzed env clones from two serially sampled patients [66]; the
sequence ‘‘C9/1997’’ from patient C was excluded from the analysis
because it has been identiﬁed previously as a recombinant [67]. In
addition, we inferred substitution rates from population sequences
sampled at different time points in four separate patients [68]. Since
only three or four sequences were available per patient, these
sequences were analyzed as one single dataset with the internal and
backbone rate calculated as the mean rate for only within-host
internal branches and backbone branches, respectively. Finally, we
analyzed data from three HIV-2 mother–child transmission pairs [37],
including unpublished sequences for one pair (P3P4). These
sequences were obtained using methods described elsewhere [37]
and are available from GenBank. Since only one sample of cloned
sequences was available for both mother and child at the same time,
rates were estimated by specifying a normal prior distribution on the
time to the most recent common ancestor based on the time of birth;
monophyletic constraints were imposed on both the mother and
child sequences. HIV-1 group M and HIV-2 alignments were trimmed
so that approximately the same gene region was investigated for all
datasets (position 823 to 1128 relative to HXB2 env and position 823
to 1134 relative to SMM239 env).
Supporting Information
Figure S1. Genealogies for Patients 2 (A), 3 (B), 5 (C), 6 (D), 7 (E), 8 (F),
9 (G), and 11 (H) Indicating Backbone, Internal, and External
Branches
The trees for each patient were selected from the Bayesian relaxed-
clock posterior distribution using a maximum clade credibility
criterion. Backbone, internal, and external branches are shown in
red, blue, and black, respectively.
Found at doi:10.1371/journal.pcbi.0030029.sg001 (684 KB PDF).
Figure S2. Scatter Plots of Mean Synonymous (A) and Nonsynon-
ymous (B) Substitution Rates on Internal Branches as a Function of
Progression Time, CD4þ T Cell Count Slope, and Log Viral Load
Slope
Rates as a function of progression time and the slope of the CD4þ T
cell count are shown in pink, while rates as a function of the log VL
slope are shown in cyan. The slope of the CD4þ T cell count and log
VL were calculated based on linear regression of these parameters as
a function of time. The error bars represent the standard errors of
the estimates. There is a signiﬁcant correlation between the log of
synonymous rates on internal branches and progression (r¼ 0.74, p¼
0.023). The same is true for the correlation with CD4þ T cell count
change over time (r ¼  0.73, p ¼ 0.026). There is no signiﬁcant
correlation with log VL change over time (r ¼ 0.53, p ¼ 0.142). No
correlations are signiﬁcant for nonsynonymous rates.
Found at doi:10.1371/journal.pcbi.0030029.sg002 (875 KB AI).
Figure S3. Scatter Plots of Mean Synonymous Substitution Rates on
Backbone (A) and Internal (B) Branches for a Restricted Number of
Time Points as a Function of Progression Time, CD4þ T Cell Count
Slope, and Log Viral Load Slope
Rates were inferred for datasets restricted to time points up to about
70 months after seroconversion (last included time point at 77, 73, 73,
68, 73, 74, 70, 63, and 70 months for patients 1, 2, 3, 5, 6, 7, 8, 9, and
11, respectively). Rates as a function of progression time and the
slope of the CD4þ T cell count are shown in pink, while rates as a
function of the log VL slope are shown in cyan. The slope of the CD4þ
T cell count and log VL were calculated based on linear regression of
these parameters as a function of time. The error bars represent the
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shows a moderate negative correlation with progression time (r ¼
 0.64, p¼0.066) and a moderate positive correlation with the change
in log VL (r ¼ 0.58, p ¼ 0.10). There is a stronger correlation with the
rate of CD4þT cell count change over time (r¼ 0.73, p¼0.023). The
log of internal rates is also signiﬁcantly correlated with progression
time (r ¼  0.68, p ¼ 0.043) and the rate of CD4þ T cell count change
over time (r ¼  0.74, p ¼ 0.022).
Found at doi:10.1371/journal.pcbi.0030029.sg003 (831 KB AI).
Table S1. Mean Internal/External Rate Ratios for Simulated and Real
Datasets
For each patient, ﬁve genealogies were simulated with the same
amount of serial samples and sequences per sample under both an
exponential growth (Expo) and a logistic growth (Log) model. Branch
lengths in time units were multiplied with the mean evolutionary rate
and rescaled to codon substitutions per codon site. Finally, sequences
were evolved along the trees using a ‘‘single dN/dS’’ codon model [69].
We also applied the same procedure but allowed rate variation by
rescaling branch lengths using branch-speciﬁc rates, drawn identi-
cally and independently from an exponential distribution. Both for
genealogy and sequence simulation, the parameters inferred from the
real data were used. The internal/external rate ratios for each patient
are listed at the bottom of the table (Real). For seven patients, the real
internal/external rate ratio is smaller than all the simulated datasets.
For two patients (3 and 9), who have the highest internal/external rate
ratio, only a single simulated dataset has a ratio lower than the real
value. The p-value is the probability of obtaining the real internal/
external rate ratio by chance alone assuming neutrality and assuming
that the 20 simulated datasets are equivalent replicates of the within-
host neutral evolutionary process.
Found at doi:10.1371/journal.pcbi.0030029.st001 (99 KB DOC).
Table S2. Recombination Rate Estimates for Each Time Point
Recombination rates were estimated using the composite likelihood
estimator [70], which has been extended to accommodate for the
general time-reversible model of nucleotide substitution [71].
Recombination rates (rho) are listed for each available time point
(Tp). The symbol * indicates that the likelihood permutation test was
signiﬁcant (p , 0.05). For each sample, the time since seroconversion
(Ts) in months and the number of segregating sites (S) in the sequence
sample is shown. The standard deviations (SD) were obtained by
repeating the estimation process ten times.
Found at doi:10.1371/journal.pcbi.0030029.st002 (172 KB DOC).
Table S3. Analysis of Among-Site Nonsynonymous and Synonymous
Rate Variation
For each patient, log likelihoods are listed for a model that allows
nonsynonymous rate variation (NS) and for a model that allows both
nonsynonymous and synonymous rate variation (Dual) among sites
[30]. Reported p-value is for the likelihood ratio test between the NS
and Dual rate variation models, using the v
2 distribution with four
degrees of freedom. Coefﬁcients of variation (CV) are listed for dN
and dS in the Dual model.
Found at doi:10.1371/journal.pcbi.0030029.st003 (36 KB DOC).
Table S4. Mean Synonymous and Nonsynonymous Substitution Rates
for Different HIV Variants
Substitution rates and standard deviations are listed in substitutions
per site per month for HIV-1 group M (subtype B, 14), HIV-1 group O
[33,36], and HIV-2 [37,63,65] datasets. The HIV-1 group M infected
patients are ordered according to increasing progression time. P3P4,
P7P8, and P9P10 are HIV-2 transmission chains (see Methods); the
estimates therefore represent the mean evolutionary rate in two
infected patients. The estimates for Shi et al. [68] represent mean
substitution rates in four individuals for which only limited sequences
were available (see Methods).
Found at doi:10.1371/journal.pcbi.0030029.st004 (60 KB DOC).
Accession numbers
The GenBank (http://www.ncbi.nlm.nih.gov/GenBank) accession num-
bers of the HIV-2 sequences discussed in this paper are DQ787116–
DQ787121.
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